Health Utility Scores of Hearing-Impaired Thais

Authors

  • Pittayapon Pitathawatchai Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
  • Wirawan Wannaro Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
  • Patchanok Pongprawat Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
  • Thara Tunthanathip Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
  • Luiz Lourencone Hospital for Rehabilitation of Craniofacial Anomalies, University of Sao Paulo, Bauru 17012-900, Brazil.

DOI:

https://doi.org/10.31584/jhsmr.201973

Keywords:

EQ-5D, hearing loss, Thai, utility scores

Abstract

Objective: To assess the health utility scores of Thais with hearing loss, which can be used as a reference value for assessing health-related quality of life and economic evaluations in any interventions among hearing-impaired persons in Thailand. 
Material and Methods: All hearing-impaired persons who visited Songklanagarind Hospital between January and June 2019 were recruited for the study. The demographic and clinical data of the participants including gender, age, and type and degree of hearing loss were collected. A health-related quality of life interview was conducted using the EuroQoL five dimensional questionnaire, Thai version. Independent t-test and multiple linear regression analysis were performed to assess which factors were associated independently with the health utility scores. 
Results: One hundred and eleven participants, 46 males and 65 females, ranging in age from 22 to 92 years, were recruited for the study. The average health utility scores were 0.81 and 0.86 for subjects not using and using hearing aids, respectively, similar to the results from other nations. The average health utility score of subjects with underlying diseases (0.79) was lower than the average health utility score of subjects without underlying diseases (0.87) with statistical significance (p-value=0.038). Additionally, the pure tone average in the better ear was the only variable significantly associated with the health utility scores (regression coefficient: -0.004, p-value=0.002). 
Conclusion: The average health utility scores among hearing-impaired Thais were 0.81 and 0.86 for subjects not using and using hearing aids, respectively.

References

1. Karchmer MA, Allen TE. The functional assessment of deaf and hard of hearing students. Am Ann Deaf 1999;144:67-77.

2. World Health Organization. Deafness prevention [homepage on the Internet]. Geneva: WHO; 2018 [cited 2019 Jul 17]. Available from: https://www.who.int/deafness/estimates/en/

3. Prasansuk S. Incidence/prevalence of sensorineural hearing impairment in Thailand and Southeast Asia. Audiology 2000;39:207-11.

4. World Health Organization. State of hearing & ear care in the south-east Asia region [homepage on the Internet]. Geneva:WHO; 2009 [cited 2018 Nov 17]. Available from: http://apps.searo.who.int/pds_docs/B1466.pdf

5. Official Statistics Registration System. Thai population 2018 [homepage on the Internet]. Bangkok: Official Statistics Registration System; 2018 [cited 2019 Aug 21]. Available from: http://stat.dopa.go.th/stat/statnew/upstat_age_disp.php

6. Office of the Civil Service Commission. Thai government manpower 2017 [homepage on the Internet]. Bangkok: OCSC;2018 [cited 2019 Aug 29]. Available from: https://www.ocsc.go.th/gmis/downloads

7. Grosse SD, Prosser LA, Asakawa K, Feeny D. QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique. Expert Rev Pharmacoecon Outcomes Res 2010;10:293-308.

8. Bos JM, Rümke H, Welte R, Postma MJ. Epidemiologic impact and cost effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands. Clin Ther 2003;25:2614-30.

9. Bos JM, Rümke HC, Welte R, Spanjaard L, van Alphen L, Postma MJ. Combination vaccine against invasive meningococcal B and pneumococcal infections. Pharmacoeconomics 2006;24:141-53.

10. Melegaro A, Edmunds WJ. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Vaccine 2004;22:4203-14.

11. Oostenbrink R, Moll HA, Essink-Bot ML. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison. J Clin Epidemiol 2002;55:791-9.

12. Tongsiri S, Cairns J. Estimating population-based values for EQ-5D health states in Thailand. Value Health 2011;14:1142-5.

13. Thavorncharoensap M. Measurement of utility. J Med Assoc Thai 2014;97:S43-9.

14. Pascolini D, Smith A. Hearing Impairment in 2008: a compilation of available epidemiological studies. Int J Audiol 2009;48:473-85.

15. Barton GR, Bankart J, Davis AC, Summerfield QA. Comparing utility scores before and after hearing-aid provision. Appl Health Econ Health Policy 2004;3:1035.

16. Pattanaphesaj J, Thavorncharoensap M, Ramos-Goñi JM, Tongsiri S, Ingsrisawang L, Teerawattananon Y. The EQ-5D-5L valuation study in Thailand. Expert Rev Pharmacoecon Outcomes Res 2018;18:551-8.

17. Helvik AS, Jacobsen G, Wennberg S, Arnesen H, Ringdahl A, Hallberg LR. Activity limitation and participation restriction in adults seeking hearing aid fitting and rehabilitation. Disabil Rehabil 2006;28:281-8.

18. Solheim J, Kværner KJ, Falkenberg ES. Daily life consequences of hearing loss in the elderly. Disabil Rehabil 2011;33:2179-85.

19. Carroll AE, Downs SM. Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr 2009;155:21-5.

20. Oostenbrink R, Moll HA, Essink-Bot ML. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison. J Clin Epidemiol 2002;55:791-9.

21. Oostenbrink R, Oostenbrink JB, Moons KG, Derksen-Lubsen G, Essink-Bot ML, Grobbee DE, et al. Cost-utility analysis of patient care in children with meningeal signs. Int J Technol Assess Health Care 2002;18:485-96.

22. Nordvik Ø, Heggdal PO, Brännström J, Vassbotn F, Aarstad AK, Aarstad HJ. Generic quality of life in persons with hearing loss: a systematic literature review. BMC Ear Nose Throat Disord 2018;18:1.

23. Barton GR, Bankart J, Davis AC, Summerfield QA. Comparing utility scores before and after hearing-aid provision. Appl Health Econ Health Policy 2004;3:103-5.

24. Joore MA, Brunenberg DE, Chenault MN, Anteunis LJ. Societal effects of hearing aid fitting among the moderately hearing impaired. Int J Audiol 2003;42:152-60.

25. Grutters JP, Joore MA, van der Horst F, Verschuure H, Dreschler WA, Anteunis LJ. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints. Qual Life Res 2007;16:1439-49.

26. Sach TH, Barton GR. Interpreting parental proxy reports of (health-related) quality of life for children with unilateral cochlear implants. Int J Pediatr Otorhinolaryngol 2007;71:435-45.

27. Kuthubutheen J, Mittmann N, Amoodi H, Qian W, Chen JM. The effect of different utility measures on the cost-effectiveness of bilateral cochlear implantation. Laryngoscope 2015;125:442-7.

28. Lee HY, Park EC, Joong Kim H, Choi JY, Kim HN. Cost-utility analysis of cochlear implants in Korea using different measures of utility. Acta Otolaryngol 2006;126:817-23.

Downloads

Published

2019-11-22

How to Cite

1.
Pitathawatchai P, Wannaro W, Pongprawat P, Tunthanathip T, Lourencone L. Health Utility Scores of Hearing-Impaired Thais. J Health Sci Med Res [Internet]. 2019 Nov. 22 [cited 2024 Apr. 27];38(1):17-24. Available from: https://he01.tci-thaijo.org/index.php/jhsmr/article/view/226396

Issue

VOL 38, NO 1(2020): Jan-Mar

Section

Original Article
Crossref
Scopus
Google Scholar
Europe PMC